PCYOX1L
Prenylcysteine oxidase 1-like
Also known as: MGC3265, PCYXL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBM8
- Gene
- PCYOX1L
- Ensembl
- ENSG00000145882
- Chromosome
- 5
- Canonical length
- 494 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Mitochondria
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Predicted to enable prenylcysteine oxidase activity. Predicted to be involved in prenylated protein catabolic process. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
494 residues, UniProt reviewed canonical sequence.
>Q8NBM8|PCYOX1L
1 MARAAPLLAA LTALLAAAAA GGDAPPGKIA VVGAGIGGSA VAHFLQQHFG PRVQIDVYEK
61 GTVGGRLATI SVNKQHYESG AASFHSLSLH MQDFVKLLGL RHRREVVGRS AIFGGEHFML
121 EETDWYLLNL FRLWWHYGIS FLRLQMWVEE VMEKFMRIYK YQAHGYAFSG VEELLYSLGE
181 STFVNMTQHS VAESLLQVGV TQRFIDDVVS AVLRASYGQS AAMPAFAGAM SLAGAQGSLW
241 SVEGGNKLVC SGLLKLTKAN VIHATVTSVT LHSTEGKALY QVAYENEVGN SSDFYDIVVI
301 ATPLHLDNSS SNLTFAGFHP PIDDVQGSFQ PTVVSLVHGY LNSSYFGFPD PKLFPFANIL
361 TTDFPSFFCT LDNICPVNIS ASFRRKQPQE AAVWRVQSPK PLFRTQLKTL FRSYYSVQTA
421 EWQAHPLYGS RPTLPRFALH DQLFYLNALE WAASSVEVMA VAAKNVALLA YNRWYQDLDK
481 IDQKDLMHKV KTELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCYOX1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 16 nTPM
- cerebellum: 13 nTPM
- cerebral cortex: 10 nTPM
- testis: 8.2 nTPM
- hypothalamus: 8 nTPM
- retina: 7 nTPM
Single-cell type
- oocytes: 28 nCPM
- platelets: 14 nCPM
- other brain neurons: 14 nCPM
- megakaryocyte progenitors: 13 nCPM
- thyrotrophs: 13 nCPM
- brain inhibitory neurons: 13 nCPM
Immune cell
- myeloid DC: 13 nTPM
- intermediate monocyte: 9.6 nTPM
- non-classical monocyte: 9.6 nTPM
- T-reg: 7.3 nTPM
- classical monocyte: 7.1 nTPM
- naive CD4 T-cell: 6.3 nTPM
Brain region
- pons: 15 nTPM
- cerebral cortex: 14 nTPM
- hypothalamus: 14 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 9.7 nTPM
- cerebellum: 9.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- neutrophil-mediated killing of bacterium
- prenylated protein catabolic process
- prenylcysteine catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PCYOX1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCYOX1L as an antibody target. Whether an autoantibody or antibody against PCYOX1L could matter depends on whether native PCYOX1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCYOX1L is annotated as secreted, so native PCYOX1L circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PCYOX1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...